Abstract
Cefamandole, a new parenteral cephalosporin antibiotic, was administered to 23 newborn infants with pustular skin infection due to Staphylococcus aureus for an average duration of 7.5 days. All the patients improved clinically. Elevation of serum glutamic oxaloacetic transaminase and eosinophilia were observed in nine infants each transiently during treatment. There were no abnormalities of renal functions and Coombs' test results remained negative. The levels of cefamandole in serum after either intravenous or intramuscular administration were higher and the mean life was longer than those previously reported in older infants, children, and adults.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Azimi P. H. Clinical and laboratory investigation of cefamandole therapy of infections in infants and children. J Infect Dis. 1978 May;137 (Suppl):S155–S160. doi: 10.1093/infdis/137.supplement.s155. [DOI] [PubMed] [Google Scholar]
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang C. T., Khan A. J., Agbayani M. M., Jhaveri R., Amin I., Evans H. E. Pharmacokinetics and safety of cefamandole in infants and children. Antimicrob Agents Chemother. 1978 Dec;14(6):838–841. doi: 10.1128/aac.14.6.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eykyn S., Jenkins C., King A., Phillips I. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. Antimicrob Agents Chemother. 1973 Jun;3(6):657–661. doi: 10.1128/aac.3.6.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fong I. W., Ralph E. D., Engelking E. R., Kirby W. M. Clinical pharmacology of cefamandole as compared with cephalothin. Antimicrob Agents Chemother. 1976 Jan;9(1):65–69. doi: 10.1128/aac.9.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Giacoia G. P., Gurodisher R. Pharmacologic principles in neonatal drug therapy. Clin Perinatol. 1975 Mar;2(1):125–138. [PubMed] [Google Scholar]
- Korzeniowski O. M., Carvalho E. M., Jr, Rocha H., Sande M. A. Evaluation of cefamandole therapy of patients with bacterial meningitis. J Infect Dis. 1978 May;137 (Suppl):S169–S179. doi: 10.1093/infdis/137.supplement.s169. [DOI] [PubMed] [Google Scholar]
- Meyers B. R., Hirschman S. Z. Antibacterial activity of cefamandole in vitro. J Infect Dis. 1978 May;137 (Suppl):S25–S31. doi: 10.1093/infdis/137.supplement.s25. [DOI] [PubMed] [Google Scholar]
- Meyers B. R., Leng B., Hirschman S. Z. Cefamandole: antimicrobial activity in vitro of a new cephalosporin. Antimicrob Agents Chemother. 1975 Dec;8(6):737–741. doi: 10.1128/aac.8.6.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neu H. C. Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. Antimicrob Agents Chemother. 1974 Aug;6(2):177–182. doi: 10.1128/aac.6.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rodriguez W. J., Ross S., Khan W. N., Goldenberg R. Clinical and laboratory evaluation of cefamandole in infants and children. J Infect Dis. 1978 May;137 (Suppl):S150–S154. doi: 10.1093/infdis/137.supplement.s150. [DOI] [PubMed] [Google Scholar]
- Steinberg E. A., Overturf G. D., Baraff L. J., Wilkins J. Penetration of cefamandole into spinal fluid. Antimicrob Agents Chemother. 1977 Jun;11(6):933–935. doi: 10.1128/aac.11.6.933. [DOI] [PMC free article] [PubMed] [Google Scholar]